Publisher
Springer Berlin Heidelberg
Reference115 articles.
1. Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman M, Wiggins JW (1985) Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 75:80–87
2. Ainsworth SB, Beresford MW, Milligan DW, Shaw NJ, Matthews JN, Fen-ton AC, Ward Piatt MP (2000) Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks’ gestation: a randomised trial. Lancet. 355:1387–1392
3. Albersheim SG, Solimano AJ, Sharma AK, Smyth JA, Rothschild A, Wood BJ, Sheps SB (1989) Randomized, double-blind, controlled trial of long-term diuretic therapy for broncho-pulmonary dysplasia. J Pediatr 115: 615–620
4. Arias Camison JM, Lau J, Cole CH, Frantz ID (1999) 3rd Meta analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants. Pediatr Pulmonol 28:167–174
5. Avery GB, Fletcher AB, Kaplan M, Brudno DS (1985) Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75:106–111